ID   AURKC_HUMAN             Reviewed;         309 AA.
AC   Q9UQB9; O60681; O75442; Q6AZY8; Q6DLZ0; Q9UPK5;
DT   17-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   12-OCT-2022, entry version 198.
DE   RecName: Full=Aurora kinase C;
DE            EC=2.7.11.1;
DE   AltName: Full=Aurora 3;
DE   AltName: Full=Aurora/IPL1-related kinase 3;
DE            Short=ARK-3;
DE            Short=Aurora-related kinase 3;
DE   AltName: Full=Aurora/IPL1/Eg2 protein 2;
DE   AltName: Full=Serine/threonine-protein kinase 13;
DE   AltName: Full=Serine/threonine-protein kinase aurora-C;
GN   Name=AURKC; Synonyms=AIE2, AIK3, AIRK3, ARK3, STK13;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND SUBCELLULAR LOCATION.
RC   TISSUE=Testis;
RX   PubMed=9809744; DOI=10.1089/dna.1998.17.823;
RA   Tseng T.-C., Chen S.-H., Hsu Y.-P.P., Tang T.K.;
RT   "Protein kinase profile of sperm and eggs: cloning and characterization of
RT   two novel testis-specific protein kinases (AIE1, AIE2) related to yeast and
RT   fly chromosome segregation regulators.";
RL   DNA Cell Biol. 17:823-833(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=9799611; DOI=10.1006/geno.1998.5522;
RA   Bernard M., Sanseau P., Henry C., Couturier A., Prigent C.;
RT   "Cloning of STK13, a third human protein kinase related to Drosophila
RT   aurora and budding yeast Ipl1 that maps on chromosome 19q13.3-ter.";
RL   Genomics 53:406-409(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Testis;
RX   PubMed=10066797; DOI=10.1074/jbc.274.11.7334;
RA   Kimura M., Matsuda Y., Yoshioka T., Okano Y.;
RT   "Cell cycle-dependent expression and centrosome localization of a third
RT   human Aurora/Ipl1-related protein kinase, AIK3.";
RL   J. Biol. Chem. 274:7334-7340(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY, FUNCTION,
RP   MUTAGENESIS OF THR-198, AND SUBCELLULAR LOCATION.
RX   PubMed=15670791; DOI=10.1016/j.bbrc.2004.12.168;
RA   Yan X., Wu Y., Li Q., Cao L., Liu X., Saiyin H., Yu L.;
RT   "Cloning and characterization of a novel human Aurora C splicing variant.";
RL   Biochem. Biophys. Res. Commun. 328:353-361(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INDUCTION, FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH INCENP, AND
RP   MUTAGENESIS OF LYS-72.
RX   PubMed=15499654; DOI=10.1002/cm.20039;
RA   Sasai K., Katayama H., Stenoien D.L., Fujii S., Honda R., Kimura M.,
RA   Okano Y., Tatsuka M., Suzuki F., Nigg E.A., Earnshaw W.C., Brinkley W.R.,
RA   Sen S.;
RT   "Aurora-C kinase is a novel chromosomal passenger protein that can
RT   complement Aurora-B kinase function in mitotic cells.";
RL   Cell Motil. Cytoskeleton 59:249-263(2004).
RN   [9]
RP   IDENTIFICATION IN THE CDC COMPLEX, SUBCELLULAR LOCATION, ACTIVITY
RP   REGULATION, FUNCTION, AND MUTAGENESIS OF LYS-72 AND THR-198.
RX   PubMed=15316025; DOI=10.1074/jbc.m403029200;
RA   Li X., Sakashita G., Matsuzaki H., Sugimoto K., Kimura K., Hanaoka F.,
RA   Taniguchi H., Furukawa K., Urano T.;
RT   "Direct association with inner centromere protein (INCENP) activates the
RT   novel chromosomal passenger protein, Aurora-C.";
RL   J. Biol. Chem. 279:47201-47211(2004).
RN   [10]
RP   IDENTIFICATION IN THE CDC COMPLEX, INTERACTION WITH BIRC5, SUBCELLULAR
RP   LOCATION, FUNCTION, AND MUTAGENESIS OF ASP-166.
RX   PubMed=15938719; DOI=10.1111/j.1365-2443.2005.00863.x;
RA   Yan X., Cao L., Li Q., Wu Y., Zhang H., Saiyin H., Liu X., Zhang X.,
RA   Shi Q., Yu L.;
RT   "Aurora C is directly associated with Survivin and required for
RT   cytokinesis.";
RL   Genes Cells 10:617-626(2005).
RN   [11]
RP   INVOLVEMENT IN SPGF5.
RX   PubMed=17435757; DOI=10.1038/ng2027;
RA   Dieterich K., Soto Rifo R., Faure A.K., Hennebicq S., Ben Amar B., Zahi M.,
RA   Perrin J., Martinez D., Sele B., Jouk P.-S., Ohlmann T., Rousseaux S.,
RA   Lunardi J., Ray P.F.;
RT   "Homozygous mutation of AURKC yields large-headed polyploid spermatozoa and
RT   causes male infertility.";
RL   Nat. Genet. 39:661-665(2007).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH TACC1.
RX   PubMed=21531210; DOI=10.1016/j.bbrc.2011.04.078;
RA   Gabillard J.C., Ulisse S., Baldini E., Sorrenti S., Cremet J.Y.,
RA   Coccaro C., Prigent C., D'Armiento M., Arlot-Bonnemains Y.;
RT   "Aurora-C interacts with and phosphorylates the transforming acidic coiled-
RT   coil 1 protein.";
RL   Biochem. Biophys. Res. Commun. 408:647-653(2011).
RN   [13]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=21493633; DOI=10.1093/humrep/der111;
RA   Avo Santos M., van de Werken C., de Vries M., Jahr H., Vromans M.J.,
RA   Laven J.S., Fauser B.C., Kops G.J., Lens S.M., Baart E.B.;
RT   "A role for Aurora C in the chromosomal passenger complex during human
RT   preimplantation embryo development.";
RL   Hum. Reprod. 26:1868-1881(2011).
RN   [14]
RP   INVOLVEMENT IN SPGF5.
RX   PubMed=21733974; DOI=10.1093/molehr/gar050;
RA   Ben Khelifa M., Zouari R., Harbuz R., Halouani L., Arnoult C., Lunardi J.,
RA   Ray P.F.;
RT   "A new AURKC mutation causing macrozoospermia: implications for human
RT   spermatogenesis and clinical diagnosis.";
RL   Mol. Hum. Reprod. 17:762-768(2011).
RN   [15]
RP   INTERACTION WITH BIRC5, SUBUNIT, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=27332895; DOI=10.1371/journal.pone.0157305;
RA   Sasai K., Katayama H., Hawke D.H., Sen S.;
RT   "Aurora-C interactions with survivin and INCENP reveal shared and distinct
RT   features compared with Aurora-B chromosome passenger protein complex.";
RL   PLoS ONE 11:E0157305-E0157305(2016).
RN   [16]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLU-52; GLN-148 AND GLN-244.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase component of the chromosomal
CC       passenger complex (CPC), a complex that acts as a key regulator of
CC       mitosis. The CPC complex has essential functions at the centromere in
CC       ensuring correct chromosome alignment and segregation and is required
CC       for chromatin-induced microtubule stabilization and spindle assembly.
CC       Also plays a role in meiosis and more particularly in spermatogenesis.
CC       Has redundant cellular functions with AURKB and can rescue an AURKB
CC       knockdown. Like AURKB, AURKC phosphorylates histone H3 at 'Ser-10' and
CC       'Ser-28'. AURKC phosphorylates the CPC complex subunits BIRC5/survivin
CC       and INCENP leading to increased AURKC activity. Phosphorylates TACC1,
CC       another protein involved in cell division, at 'Ser-228'.
CC       {ECO:0000269|PubMed:15316025, ECO:0000269|PubMed:15499654,
CC       ECO:0000269|PubMed:15670791, ECO:0000269|PubMed:15938719,
CC       ECO:0000269|PubMed:21493633, ECO:0000269|PubMed:21531210,
CC       ECO:0000269|PubMed:27332895}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- ACTIVITY REGULATION: Okadaic acid, an inhibitor of protein phosphatase
CC       1 (PP1), protein phosphatase 2A (PP2A) and protein phosphatase 5 (PP5),
CC       increases AURKC activity. AURKC is also stabilized through its
CC       interaction with INCENP, which acts also as an activator.
CC       {ECO:0000269|PubMed:15316025}.
CC   -!- SUBUNIT: Component of the chromosomal passenger complex (CPC) composed
CC       of at least BIRC5/survivin, CDCA8/borealin, INCENP, AURKB or AURKC;
CC       predominantly independent AURKB- and AURKC-containing complexes exist;
CC       in the complex interacts directly with BIRC5/survivin and INCENP.
CC       Interacts with TACC1. {ECO:0000269|PubMed:15316025,
CC       ECO:0000269|PubMed:15499654, ECO:0000269|PubMed:15938719,
CC       ECO:0000269|PubMed:21531210, ECO:0000269|PubMed:27332895}.
CC   -!- INTERACTION:
CC       Q9UQB9; O15392: BIRC5; NbExp=10; IntAct=EBI-3926851, EBI-518823;
CC       Q9UQB9; Q96CA5: BIRC7; NbExp=3; IntAct=EBI-3926851, EBI-517623;
CC       Q9UQB9; A2RRN7: CADPS; NbExp=3; IntAct=EBI-3926851, EBI-10179719;
CC       Q9UQB9; Q9NQS7: INCENP; NbExp=17; IntAct=EBI-3926851, EBI-307907;
CC       Q9UQB9; P32243-2: OTX2; NbExp=4; IntAct=EBI-3926851, EBI-9087860;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome. Chromosome, centromere
CC       {ECO:0000269|PubMed:27332895}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000269|PubMed:15938719}. Note=Distributes in the condensed
CC       chromosomes during prophase to metaphase. After entering anaphase,
CC       there is a dissociation from separated chromosomes and a redistribution
CC       to midzone microtubules, and finally remains in the midbody during
CC       cytokinesis. {ECO:0000269|PubMed:21531210}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UQB9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UQB9-2; Sequence=VSP_004872;
CC       Name=3; Synonyms=Aurora C-SV;
CC         IsoId=Q9UQB9-3; Sequence=VSP_041095;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 2 are expressed in testis.
CC       Elevated expression levels were seen only in a subset of cancer cell
CC       lines such as Hep-G2, Huh-7 and HeLa. Expression is maximum at M phase.
CC       {ECO:0000269|PubMed:15670791}.
CC   -!- INDUCTION: Expression is cell cycle-regulated, with an increase during
CC       G2 and M phases. {ECO:0000269|PubMed:10066797,
CC       ECO:0000269|PubMed:15499654}.
CC   -!- DISEASE: Spermatogenic failure 5 (SPGF5) [MIM:243060]: An infertility
CC       disorder caused by spermatogenesis defects. Semen from affected men
CC       show close to 100% morphologically abnormal multiflagellar spermatozoa
CC       with low motility, oversized irregular heads, and abnormal midpiece and
CC       acrosome. {ECO:0000269|PubMed:17435757, ECO:0000269|PubMed:21733974}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. Aurora subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF054621; AAC25955.1; -; mRNA.
DR   EMBL; AF059681; AAC77369.1; -; mRNA.
DR   EMBL; AB017332; BAA76292.1; -; mRNA.
DR   EMBL; AY661554; AAT64422.1; -; mRNA.
DR   EMBL; AC005261; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471135; EAW72485.1; -; Genomic_DNA.
DR   EMBL; BC075064; AAH75064.2; -; mRNA.
DR   CCDS; CCDS33128.1; -. [Q9UQB9-1]
DR   CCDS; CCDS46205.1; -. [Q9UQB9-3]
DR   CCDS; CCDS46206.1; -. [Q9UQB9-2]
DR   RefSeq; NP_001015878.1; NM_001015878.1. [Q9UQB9-1]
DR   RefSeq; NP_001015879.1; NM_001015879.1. [Q9UQB9-3]
DR   RefSeq; NP_003151.2; NM_003160.2. [Q9UQB9-2]
DR   PDB; 6GR8; X-ray; 1.75 A; A=36-305.
DR   PDB; 6GR9; X-ray; 2.25 A; A=36-305.
DR   PDBsum; 6GR8; -.
DR   PDBsum; 6GR9; -.
DR   AlphaFoldDB; Q9UQB9; -.
DR   SMR; Q9UQB9; -.
DR   BioGRID; 112671; 34.
DR   IntAct; Q9UQB9; 30.
DR   STRING; 9606.ENSP00000302898; -.
DR   BindingDB; Q9UQB9; -.
DR   ChEMBL; CHEMBL3935; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugBank; DB06134; SNS-314.
DR   DrugCentral; Q9UQB9; -.
DR   GuidetoPHARMACOLOGY; 1938; -.
DR   iPTMnet; Q9UQB9; -.
DR   PhosphoSitePlus; Q9UQB9; -.
DR   BioMuta; AURKC; -.
DR   DMDM; 27805738; -.
DR   EPD; Q9UQB9; -.
DR   jPOST; Q9UQB9; -.
DR   MassIVE; Q9UQB9; -.
DR   MaxQB; Q9UQB9; -.
DR   PaxDb; Q9UQB9; -.
DR   PeptideAtlas; Q9UQB9; -.
DR   PRIDE; Q9UQB9; -.
DR   ProteomicsDB; 85538; -. [Q9UQB9-1]
DR   ProteomicsDB; 85539; -. [Q9UQB9-2]
DR   ProteomicsDB; 85540; -. [Q9UQB9-3]
DR   Antibodypedia; 33237; 510 antibodies from 29 providers.
DR   DNASU; 6795; -.
DR   Ensembl; ENST00000302804.12; ENSP00000302898.6; ENSG00000105146.14. [Q9UQB9-1]
DR   Ensembl; ENST00000415300.6; ENSP00000407162.1; ENSG00000105146.14. [Q9UQB9-3]
DR   Ensembl; ENST00000598785.5; ENSP00000471830.1; ENSG00000105146.14. [Q9UQB9-2]
DR   GeneID; 6795; -.
DR   KEGG; hsa:6795; -.
DR   MANE-Select; ENST00000302804.12; ENSP00000302898.6; NM_001015878.2; NP_001015878.1.
DR   UCSC; uc002qoc.4; human. [Q9UQB9-1]
DR   CTD; 6795; -.
DR   DisGeNET; 6795; -.
DR   GeneCards; AURKC; -.
DR   HGNC; HGNC:11391; AURKC.
DR   HPA; ENSG00000105146; Tissue enriched (testis).
DR   MalaCards; AURKC; -.
DR   MIM; 243060; phenotype.
DR   MIM; 603495; gene.
DR   neXtProt; NX_Q9UQB9; -.
DR   OpenTargets; ENSG00000105146; -.
DR   Orphanet; 137893; Male infertility due to large-headed multiflagellar polyploid spermatozoa.
DR   PharmGKB; PA36200; -.
DR   VEuPathDB; HostDB:ENSG00000105146; -.
DR   eggNOG; KOG0580; Eukaryota.
DR   GeneTree; ENSGT00940000161619; -.
DR   HOGENOM; CLU_000288_63_0_1; -.
DR   InParanoid; Q9UQB9; -.
DR   OMA; EKEGMEH; -.
DR   OrthoDB; 954262at2759; -.
DR   PhylomeDB; Q9UQB9; -.
DR   TreeFam; TF105331; -.
DR   PathwayCommons; Q9UQB9; -.
DR   SignaLink; Q9UQB9; -.
DR   SIGNOR; Q9UQB9; -.
DR   BioGRID-ORCS; 6795; 12 hits in 1111 CRISPR screens.
DR   GeneWiki; AURKC; -.
DR   GenomeRNAi; 6795; -.
DR   Pharos; Q9UQB9; Tchem.
DR   PRO; PR:Q9UQB9; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9UQB9; protein.
DR   Bgee; ENSG00000105146; Expressed in oocyte and 99 other tissues.
DR   ExpressionAtlas; Q9UQB9; baseline and differential.
DR   Genevisible; Q9UQB9; HS.
DR   GO; GO:0032133; C:chromosome passenger complex; IBA:GO_Central.
DR   GO; GO:0000775; C:chromosome, centromeric region; IEA:UniProtKB-SubCell.
DR   GO; GO:0000793; C:condensed chromosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0030496; C:midbody; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005819; C:spindle; TAS:UniProtKB.
DR   GO; GO:0005876; C:spindle microtubule; IBA:GO_Central.
DR   GO; GO:0051233; C:spindle midzone; IDA:UniProtKB.
DR   GO; GO:0031616; C:spindle pole centrosome; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0035174; F:histone serine kinase activity; IBA:GO_Central.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; TAS:UniProtKB.
DR   GO; GO:0008608; P:attachment of spindle microtubules to kinetochore; TAS:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0016570; P:histone modification; TAS:UniProtKB.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051256; P:mitotic spindle midzone assembly; TAS:UniProtKB.
DR   GO; GO:0007052; P:mitotic spindle organization; IBA:GO_Central.
DR   GO; GO:0048599; P:oocyte development; IEA:InterPro.
DR   GO; GO:0032467; P:positive regulation of cytokinesis; TAS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0032465; P:regulation of cytokinesis; IBA:GO_Central.
DR   GO; GO:0007283; P:spermatogenesis; IEA:InterPro.
DR   InterPro; IPR030616; Aur.
DR   InterPro; IPR030613; AURKC.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24350; PTHR24350; 1.
DR   PANTHER; PTHR24350:SF3; PTHR24350:SF3; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell cycle; Cell division;
KW   Centromere; Chromosome; Cytoplasm; Cytoskeleton; Kinase; Meiosis; Mitosis;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..309
FT                   /note="Aurora kinase C"
FT                   /id="PRO_0000085660"
FT   DOMAIN          43..293
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..33
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          292..309
FT                   /note="Interaction with BIRC5"
FT                   /evidence="ECO:0000269|PubMed:27332895"
FT   COMPBIAS        19..33
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        166
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         49..57
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         72
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         198
FT                   /note="Phosphothreonine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:O88445"
FT   VAR_SEQ         1..34
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9799611"
FT                   /id="VSP_004872"
FT   VAR_SEQ         1..20
FT                   /note="MSSPRAVVQLGKAQPAGEEL -> M (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15670791"
FT                   /id="VSP_041095"
FT   VARIANT         52
FT                   /note="G -> E (in a lung adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040385"
FT   VARIANT         148
FT                   /note="E -> Q (in a lung squamous cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040386"
FT   VARIANT         244
FT                   /note="H -> Q (in a lung adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040387"
FT   MUTAGEN         72
FT                   /note="K->R: Impairs kinase activity."
FT                   /evidence="ECO:0000269|PubMed:15316025,
FT                   ECO:0000269|PubMed:15499654"
FT   MUTAGEN         166
FT                   /note="D->Y: Impairs kinase activity, and keeps AURKC with
FT                   the chromosomes until the end of mitosis."
FT                   /evidence="ECO:0000269|PubMed:15938719"
FT   MUTAGEN         198
FT                   /note="T->A: Impairs kinase activity."
FT                   /evidence="ECO:0000269|PubMed:15316025,
FT                   ECO:0000269|PubMed:15670791"
FT   CONFLICT        109
FT                   /note="Y -> H (in Ref. 1; AAC25955)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        150
FT                   /note="L -> V (in Ref. 2; AAC77369)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        193..195
FT                   /note="SLR -> LPE (in Ref. 2; AAC77369)"
FT                   /evidence="ECO:0000305"
FT   HELIX           40..42
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   STRAND          43..52
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   STRAND          55..62
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   TURN            63..65
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   STRAND          68..75
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   HELIX           76..82
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   HELIX           85..97
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   STRAND          106..111
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   STRAND          113..120
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   HELIX           128..135
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   HELIX           140..159
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   HELIX           169..171
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   STRAND          172..174
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   STRAND          180..182
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   HELIX           203..205
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   HELIX           208..211
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   HELIX           220..234
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   HELIX           244..252
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   HELIX           264..273
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   HELIX           278..280
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   HELIX           284..289
FT                   /evidence="ECO:0007829|PDB:6GR8"
FT   HELIX           291..296
FT                   /evidence="ECO:0007829|PDB:6GR8"
SQ   SEQUENCE   309 AA;  35591 MW;  41B7DFCA91704201 CRC64;
     MSSPRAVVQL GKAQPAGEEL ATANQTAQQP SSPAMRRLTV DDFEIGRPLG KGKFGNVYLA
     RLKESHFIVA LKVLFKSQIE KEGLEHQLRR EIEIQAHLQH PNILRLYNYF HDARRVYLIL
     EYAPRGELYK ELQKSEKLDE QRTATIIEEL ADALTYCHDK KVIHRDIKPE NLLLGFRGEV
     KIADFGWSVH TPSLRRKTMC GTLDYLPPEM IEGRTYDEKV DLWCIGVLCY ELLVGYPPFE
     SASHSETYRR ILKVDVRFPL SMPLGARDLI SRLLRYQPLE RLPLAQILKH PWVQAHSRRV
     LPPCAQMAS
//
